300+ investors in your industry, stage, and region Get
Any industry
EdTech
Venture Capital
Video Games
Hospitality
Restaurants
Crowdfunding
Photography
Cryptocurrency
Digital Media
Big Data
Email
Artificial Intelligence
Clean Energy
Non Profit
Social Impact
Energy
SaaS
Google
CleanTech
Consumer
Health Care
Enterprise Software
Local
Travel
Platforms
InsurTech
Financial Services
Oil and Gas
Construction
Mobile
Payments
Retail
Film
Marketplace
Organic Food
Fitness
Machine Learning
Agriculture (AgTech)
Gaming
Social Network
B2B
Medical Device
Wellness
Education
Sports
Legal
Automotive
eSports
Biotechnology
Renewable Energy
Facebook
Blockchain
Software
Theatre
Medical
Web3
Recruiting
Beauty
Fashion
Infrastructure
Social
Celebrity
Cannabis
LGBT
Climate
Food and Beverage
Life Science
Publishing
Wine and Spirits
Mobile Apps
Real Estate
Sporting Goods
Music
Art
Finance
Manufacturing
FinTech
Social Media
Franchise
Internet
Mobile Advertising
Android
Impact
Proptech
Hardware
Transportation
Biotech
Sustainability
Enterprise
Community
Media (Entertainment)
Any country
Afghanistan
Greece
Thailand
United Arab Emirates
Andorra
Dominica
Japan
Brazil
Singapore
Burkina Faso
Africa
LATAM
Egypt
United Kingdom
Oceania
Argentina
Tunisia
Taiwan
Zimbabwe
Faroe Islands
South Korea
Hong Kong
Benin
Nigeria
Togo
Gibraltar
Croatia
Guinea
Sudan
Kyrgyzstan
Norway
Malawi
Isle of Man
Haiti
Iran
Lesotho
Madagascar
Russian Federation
Nepal
Pakistan
Turkey
Mexico
Liberia
Tajikistan
Sweden
Romania
Zambia
Oman
Poland
Puerto Rico
Guernsey
Cameroon
Colombia
China
Armenia
Côte d'Ivoire
Costa Rica
Czech Republic
Kuwait
Marshall Islands
Malta
Luxembourg
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
Morocco
Australia
Jamaica
Sri Lanka
Guatemala
New Zealand
Switzerland
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uganda
Uruguay
Moldova
Seychelles
Botswana
Paraguay
France
South Africa
Denmark
Georgia
Ghana
Iraq
Sierra Leone
Philippines
El Salvador
Portugal
Senegal
India
Canada
Germany
Ireland
Saudi Arabia
Kenya
Mali
Malaysia
Latvia
Rwanda
Tanzania
United States
Indonesia
Middle East
Dominican Republic
Asia
Bermuda
Albania
Spain
Bangladesh
Barbados
Belgium
Angola
Europe
Austria
Ethiopia
Cyprus
Jordan
Azerbaijan
Ecuador
Qatar
Bulgaria
Bahamas
Bolivia
Bahrain
Belize
Jersey
Algeria
Estonia
Belarus
Hungary
Finland
Italy
Grenada
Israel
Liechtenstein
Honduras
Lithuania
Cambodia
Iceland
Lebanon
Mongolia
Slovenia
Peru
San Marino
Ukraine
Vietnam
Chile
Angel Investors
VC Funds
All Investors
Download Find emails Save list
Open database

Top 50 Biotechnology Startup Investors in Japan (November 2026)

The most active venture capital funds and angel investors investing in Japan Biotechnology startups. This investor list is updated monthly from the Shizune investor database, ranked by number of investments in Japan Biotechnology startup companies. Find investors to raise a Seed, Series A or Venture - Series Unknown round with Shizune.
Investor Relevant Deals Geography Stage Focus Round Size
Mitsubishi UFJ Capital
VC Fund
31 Japan, United States, Israel Venture - Series Unknown, Series A, Seed Software, Information Technology, Manufacturing $482k–$19M
SMBC Venture Capital
VC Fund
27 Japan, United States, Singapore Venture - Series Unknown, Series A, Series B Software, Information Technology, Health Care $712k–$34M
UntroD Capital
VC Fund
22 Japan, Singapore, Austria Seed, Venture - Series Unknown, Series A Manufacturing, Biotechnology, Health Care $316k–$15M
ANRI
VC Fund
21 Japan, United States, Indonesia Seed, Series A, Venture - Series Unknown Software, Health Care, Information Technology $253k–$34M
Fast Track Initiative, Inc.
VC Fund
19 Japan, United States, United Kingdom Series A, Series B, Seed Health Care, Biotechnology, Medical $345k–$117M
Osaka University Venture Capital
VC Fund
19 Japan Seed, Venture - Series Unknown, Series A Biotechnology, Health Care, Medical $480k–$19M
JAFCO
VC Fund
16 Japan, United States, India Series A, Series B, Venture - Series Unknown Information Technology, Software, Artificial Intelligence $1.4M–$36M
UTEC - The University of Tokyo Edge Capital Partners
VC Fund
15 Japan, United States, India Series A, Seed, Series B Health Care, Biotechnology, Medical $624k–$20M
Mizuho Capital
VC Fund
15 Japan, United States, Singapore Venture - Series Unknown, Series A, Series B Information Technology, Software, Artificial Intelligence $581k–$47M
Keio Innovation Initiative
VC Fund
14 Japan, United Kingdom Series A, Seed, Venture - Series Unknown Health Care, Medical, Biotechnology $826k–$41M
Real Tech Japan
VC Fund
11 Japan, Singapore, Austria Venture - Series Unknown, Seed, Series A Manufacturing, Biotechnology, Robotics $316k–$21M
Miyako Capital
VC Fund
10 Japan, United States, United Kingdom Series A, Seed, Series B Medical, Biotechnology, Information Technology $395k–$150M
SBI Investment
VC Fund
10 Japan, United States, South Korea Series B, Series A, Venture - Series Unknown Software, Information Technology, Financial Services $1.3M–$62M
DBJ Capital
VC Fund
10 Japan, United States, Australia Series A, Venture - Series Unknown, Series B Health Care, Software, Biotechnology $976k–$34M
Nissay Capital
VC Fund
9 Japan, United States, Ethiopia Venture - Series Unknown, Seed, Series A Health Care, Software, Information Technology $455k–$11M
Japan Science and Technology Agency
VC Fund
9 Japan Series A, Seed, Venture - Series Unknown Biotechnology, Medical, Manufacturing $975k–$15M
DG Daiwa Ventures
VC Fund
8 Japan, United States, India Seed, Series A, Venture - Series Unknown Software, FinTech, Artificial Intelligence $367k–$19M
Nippon Venture Capital
VC Fund
8 Japan, United States, Indonesia Venture - Series Unknown, Series A, Series B Software, Health Care, Information Technology $457k–$35M
Kyogin Lease & Capital
VC Fund
7 Japan Series A, Venture - Series Unknown, Seed Manufacturing, Medical, Information Technology $90k–$16M
Miraidoa
VC Fund
7 Japan, United States, Myanmar Venture - Series Unknown, Seed, Series A Manufacturing, Health Care, Information Technology $96k–$11M
Angel Bridge
VC Fund
7 Japan Series A, Seed, Series B Information Technology, Software, Consulting $648k–$47M
IT-Farm
VC Fund
6 United States, Japan, Germany Seed, Series A, Series B Software, Health Care, Medical $1M–$36M
Senshu Ikeda Capital
VC Fund
6 Japan Venture - Series Unknown, Series A, Seed Software, Manufacturing, Internet $395k–$17M
JIC Venture Growth Investments
VC Fund
5 Japan, United States, Singapore Series B, Series C, Series A Information Technology, Medical, Software $3.1M–$77M
F-Prime
VC Fund
5 United States, China, United Kingdom Series A, Series B, Seed Health Care, Biotechnology, Medical $1.6M–$112M
Global Brain Corporation
VC Fund
5 Japan, United States, South Korea Series A, Series B, Venture - Series Unknown Software, Artificial Intelligence, Information Technology $516k–$48M
D3
VC Fund
5 Japan, United States Series A, Seed, Series B Biotechnology, Therapeutics, Manufacturing $690k–$51M
FFG Venture Business Partners
VC Fund
5 Japan, Indonesia, United States Series A, Venture - Series Unknown, Seed Software, Artificial Intelligence, Health Care $547k–$50M
Delight Ventures
VC Fund
4 Japan, United States, Malaysia Seed, Series A, Series B Software, Artificial Intelligence, Information Technology $556k–$19M
Incubate Fund
VC Fund
4 Japan, United States, India Seed, Series A, Venture - Series Unknown Software, Information Technology, Artificial Intelligence $289k–$20M
Innovation Network Corporation of Japan
VC Fund
4 Japan, United States, United Kingdom Venture - Series Unknown, Series B, Series A Manufacturing, Software, Medical $2.5M–$156M
SBI Group
VC Fund
4 Japan, United States, United Kingdom Series A, Series B, Series C Financial Services, FinTech, Finance $2.8M–$134M
Remiges Ventures
VC Fund
4 United States, Japan, Canada Series A, Series B, Seed Biotechnology, Medical, Health Care $2.6M–$41M
Fujifilm
VC Fund
4 Japan, United States, China Series A, Venture - Series Unknown, Corporate Round Biotechnology, Health Care, Medical $1.3M–$1.7B
Tsukuba Institute of Research
VC Fund
4 Japan Series A, Seed Medical, Manufacturing, Health Care $953k–$7.1M
Eight Roads Ventures
VC Fund
4 United States, China, India Series B, Series A, Series C Health Care, Software, Biotechnology $6M–$117M
Daiwa Corporate Investment
VC Fund
4 Japan, United States, France Venture - Series Unknown, Series A, Seed Software, Manufacturing, Health Care $310k–$9.2M
Glocalink
VC Fund
4 Japan, Singapore, United Kingdom Seed, Venture - Series Unknown Health Care, Robotics, Biotechnology $41k–$3.3M
Capital Medica Ventures
VC Fund
4 Japan Seed, Series A, Venture - Series Unknown Health Care, Medical, Software $91k–$51M
QB Capital
VC Fund
3 Japan, Singapore, United States Seed, Series A Manufacturing, Medical, Biotechnology $641k–$213M
Sosei CVC
VC Fund
3 Japan Series A, Series B Biotechnology, Medical, Pharmaceutical
Universal Materials Incubator
VC Fund
3 Japan, United States, India Series A, Series B Manufacturing, Biotechnology, Chemical $2M–$99M
WASEDA University Ventures
VC Fund
3 Japan, United States, United Kingdom Seed, Series A, Convertible Note Medical, Biotechnology, Information Technology $1.2M–$38M
NEDO
VC Fund
3 Japan, United States Grant, Series A, Seed Medical, Health Care, Biotechnology $800k–$26M
Euglena
VC Fund
3 Japan, United States Seed, Series A, Venture - Series Unknown Health Care, Biotechnology, Food and Beverage $527k–$5.6M
STRIVE
VC Fund
3 Japan, India, Indonesia Seed, Series A, Series B Software, E-Commerce, Internet $500k–$25M
Chugin Capital Partner
VC Fund
3 Japan Series A, Seed, Series B Manufacturing, Software, Information Technology $246k–$54M
Antler
VC Fund
3 United States, Singapore, Australia Pre-Seed, Seed, Series A Software, Artificial Intelligence, Information Technology $100k–$29M
Higin Capital
VC Fund
3 Japan Series A, Series B, Venture - Series Unknown Medical, Biotechnology, Software $279k–$17M
SPARX Group
VC Fund
3 Japan, United States, United Kingdom Venture - Series Unknown, Series B, Series A Software, Artificial Intelligence, Information Technology $2.5M–$142M
Access all 666 investors in Japan Biotechnology startups.

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Investor list

Mitsubishi UFJ Capital
VC Fund · Tokyo, Tokyo, Japan · 31 investments in Japan Biotechnology startups

Mitsubishi UFJ Capital is a venture capital firm focusing on life science, ICT, and high technology investments.

Show more...

Investment focus

  • Industry: Software, Information Technology, Manufacturing
  • Stage:Venture - Series Unknown, Series A, Seed
  • Geography: Japan, United States, Israel

Investor stats

  • Total investments: 711
  • Round size: Seed $482k–$16M; Series A $1.2M–$19M; Venture - Series Unknown $525k–$11M
  • Lead/follow: 10% lead, 90% follow
  • Last fund: May invest from a new fund soon — raised $94M in 2020

Portfolio highlights

  • Caguuu — Caguuu offers high-quality designer furniture at affordable prices, through e-commerce, eliminating middlemen and store operating costs.
  • Luxna Biotech — Luxana Biotech is a biotechnology firm dedicated to promoting the practical use of safe and effective nucleic acid therapies. Utilizing nucleic acid chemistry technology, the company strives to provide nucleic acid medicines to patients suffering from diseases that currently lack effective treatments.
  • Link Therapeutics — Link Therapeutics specializes in developing therapeutic methods for targeting autoantibodies and identifying pathogenic autoantibodies.
Show all investments...

SMBC Venture Capital
VC Fund · Tokyo, Tokyo, Japan · 27 investments in Japan Biotechnology startups

Sumitomo Mitsui Banking Corporation (SMBC) and its group companies offer a broad range of financial services centered on banking. They are also engaged in the leasing, securities, credit card, investment, mortgage securitization, venture capital and other credit related businesses. The following lists the activities of SMBC, its subsidiaries and affiliates in the various business segments.

Show more...

Investment focus

  • Industry: Software, Information Technology, Health Care
  • Stage:Venture - Series Unknown, Series A, Series B
  • Geography: Japan, United States, Singapore

Investor stats

  • Total investments: 694
  • Round size: Series A $1.1M–$21M; Series B $2.3M–$34M; Venture - Series Unknown $712k–$12M
  • Lead/follow: 4% lead, 96% follow
  • Last fund: May invest from a new fund soon — last raise in 2019

Portfolio highlights

  • LQUOM — QWAVE offers cryptography communication technology.
  • Etaily — Etaily provides e-commerce and retail solutions in the Philippines, enabling brands with end-to-end services, from store management to fulfillment.
  • Link Therapeutics — Link Therapeutics specializes in developing therapeutic methods for targeting autoantibodies and identifying pathogenic autoantibodies.
Show all investments...

UntroD Capital
VC Fund · Sumida, Tokyo, Japan · 22 investments in Japan Biotechnology startups, 10 in the past 12 months

UntroD Capital is an R&D-based innovative technology that specializes in social implementation.

Show more...

Investment focus

  • Industry: Manufacturing, Biotechnology, Health Care
  • Stage:Seed, Venture - Series Unknown, Series A
  • Geography: Japan, Singapore, Austria

Investor stats

  • Total investments: 149
  • Round size: Seed $316k–$6M; Series A $2.1M–$15M; Venture - Series Unknown $438k–$10M
  • Lead/follow: 42% lead, 58% follow
  • Last fund: Likely still investing — fund raised in 2024

Portfolio highlights

  • JAOPS — JAOPS is dedicated to Operations as a Service and develops software, tools, and services for space mission operations, including data processing, mission planning, context evaluation, anomaly resolution, and real-time mission control and monitoring. The company provides mission operations design, training, and certification for operators, astronauts, and ground segment teams. JAOPS offers products such as Yamcs Gateway, mission control tools, and simulation environments to support spacecraft and lunar rover missions. Its services include turnkey mission control center design and deployment, operational reviews, and operations as a service. JAOPS works with open-source platforms like Yamcs, Grafana, and robotics simulators to support Earth orbit, cislunar, and lunar surface missions.
  • Teragen Energy — Teragen Energy develops an energy technology platform based on advanced regenerative solid oxide fuel cells that provide both power generation and energy storage in a single system. The company’s systems generate electricity from external fuels such as natural gas or hydrogen without combustion and can operate in reverse to store power as hydrogen.Teragen designs modular systems that can be scaled from megawatt-scale installations for data centers to deployments for microgrids, renewable projects, and utilities. Its technology is intended to help operators manage variable renewable output, ride through outages, and address daily capacity needs using one device. Teragen focuses on applications including AI and cloud data centers, manufacturing and cold storage facilities, remote communities, and electric grid infrastructure. The platform is positioned to replace separate diesel generators and battery systems by combining fuel-flexible generation and low-cost storage in a compact footprint.
  • Blue Whale Energy — Blue Whale Energy empowers businesses to maximize energy storage, driving a smarter, cleaner, and more reliable energy.
Show all investments...

ANRI
VC Fund · Tokyo, Tokyo, Japan · 21 investments in Japan Biotechnology startups

ANRI is a Japanese venture capital firm that mainly invests in seed and early-stage startups.

Show more...

Investment focus

  • Industry: Software, Health Care, Information Technology
  • Stage:Seed, Series A, Venture - Series Unknown
  • Geography: Japan, United States, Indonesia

Investor stats

  • Total investments: 324
  • Round size: Seed $253k–$9.4M; Series A $967k–$34M; Venture - Series Unknown $619k–$9.1M
  • Lead/follow: 25% lead, 75% follow
  • Last fund: Likely still investing — raised $102M in 2022

Portfolio highlights

  • Any Style — Any Style develops a messaging app from voice actors that regularly sends messages via subscription. It also engages in the planning and production of audio content and the VTuber production business.
  • Green Growth Co. — Green Growth Co. is a startup company engaged in next-generation infrastructure projects centered on renewable energy. The company develops grid-scale battery storage facilities and solar power plants, as well as revitalizes and trades secondary solar assets, thereby creating power sources for both local communities and corporations. It also supports the enhancement of power source value through initiatives such as the digitalization of existing generation facilities, repowering, conversion to the Feed-in Premium scheme, and the co-location of battery storage systems. Furthermore, by aggregating distributed renewable energy resources—via services such as aggregation, Power Purchase Agreements and retail supply—the company implements mechanisms to optimize supply and demand while fostering a circular flow of electricity within local regions. Green Growth also provides hands-on support to companies, assisting them with their Green Transformation initiatives as well as the formulation of power business strategies and the design of operational schemes.
  • Typewriter Therapeutics — Typewriter Therapeutics, Inc. develops mRNA-based gene therapies using a gene writing, or gene writing, platform for precise insertion of therapeutic genes into the genome. The company builds on transposon-based technologies originating from research by Professor Emeritus Haruhiko Fujiwara at the University of Tokyo. Its programs focus on all‑RNA,nonviral gene writing systems that repurpose natural genetic elements to address severe genetic disorders with limited treatment options. Typewriter Therapeutics conducts research and development across its U.S. and Japan operations and collaborates with investors and partners to advance genetic medicine candidates toward the clinic.
Show all investments...

Fast Track Initiative, Inc.
VC Fund · Hongo, Tokyo, Japan · 19 investments in Japan Biotechnology startups, 8 in the past 12 months

Fast Track Initiative is a venture capital firm with an exclusive focus on life sciences and healthcare services.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical
  • Stage:Series A, Series B, Seed
  • Geography: Japan, United States, United Kingdom

Investor stats

  • Total investments: 85
  • Round size: Seed $345k–$117M; Series A $3M–$51M; Series B $4.7M–$83M
  • Lead/follow: 27% lead, 73% follow
  • Last fund: May invest from a new fund soon — raised $124M in 2021

Portfolio highlights

  • RegCell — RegCell aims to generate novel therapeutic technologies through augmenting or controlling the immune system and our goal is to save patients who suffer from autoimmune diseases and cancer .
  • NovAccel — NovAccel operates as a deep tech company, ensure a stable supply of medical radioisotopes.
  • Neusignal Therapeutics — Neusignal Therapeutics is a medical company that develops therapeutic medicines for dementia and psychiatric illnesses.
Show all investments...

Osaka University Venture Capital
VC Fund · Osaka, Osaka, Japan · 19 investments in Japan Biotechnology startups

Osaka University Venture Capital is a venture capital firm that focuses on early-stage ventures in the fields of life innovation, green innovation, and platform technology. The firm was founded in 2014 and based in Osaka, Japan.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Seed, Venture - Series Unknown, Series A
  • Geography: Japan

Investor stats

  • Total investments: 93
  • Round size: Seed $480k–$4.5M; Series A $1.5M–$19M; Venture - Series Unknown $751k–$3.5M
  • Lead/follow: 34% lead, 66% follow
  • Last fund: May invest from a new fund soon — raised $92M in 2021

Portfolio highlights

  • JiMED — JiMED designs & develops AI based brain-computer interface for implant in ALS patients to improve communication.
  • LQUOM — QWAVE offers cryptography communication technology.
  • RegCell — RegCell aims to generate novel therapeutic technologies through augmenting or controlling the immune system and our goal is to save patients who suffer from autoimmune diseases and cancer .
Show all investments...

JAFCO
VC Fund · Tokyo, Tokyo, Japan · 16 investments in Japan Biotechnology startups

Since its founding in 1973, JAFCO has always worked with leading-edge entrepreneurs. The total capital commitments of its investment funds in Japan and overseas have exceeded 1 trillion yen and the number of portfolio IPOs to date has reached over 1,000. In addition to venture investment, JAFCO also carries out buyout investment and commit to the creations of innovative technologies and services worldwide. As entrepreneurs’ closest partner in bringing their visions to life, JAFCO provides support in areas of HR, marketing/ sales, and back-office operations, in addition to providing financing.

Show more...

Investment focus

  • Industry: Information Technology, Software, Artificial Intelligence
  • Stage:Series A, Series B, Venture - Series Unknown
  • Geography: Japan, United States, India

Investor stats

  • Total investments: 391
  • Round size: Series A $2M–$33M; Series B $4.2M–$36M; Venture - Series Unknown $1.4M–$13M
  • Lead/follow: 36% lead, 64% follow
  • Last fund: May invest from a new fund soon — raised $567M in 2019

Portfolio highlights

  • CaTe — CaTe is based in Tokyo. CaTe develops and manufactures a Digital Therapeutic (DTx) for remote cardiac rehabilitation. Their invention allows heart disease patients to safely and successfully complete cardiac rehabilitation utilizing standing exercise in a confined space, such as at home, without the use of ergometers or similar instruments.
  • ADiXi — Adixi is a tech-driven business that supports the idea that people and technology may work together. It strives to open doors by utilizing cutting-edge technology, such as artificial intelligence, to promote long-term, sustainable corporate and societal progress.
  • Alxtal — Alxtal is a tech company who optimize the development, design, and manufacturing processes of the manufacturing industry with IT and AI.
Show all investments...

UTEC - The University of Tokyo Edge Capital Partners
VC Fund · Tokyo, Tokyo, Japan · 15 investments in Japan Biotechnology startups

UTEC-The University of Tokyo Edge Capital Partners Co., Ltd.. UTEC is a seed/early stage technology focused venture capital firm associated with The University of Tokyo.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical
  • Stage:Series A, Seed, Series B
  • Geography: Japan, United States, India

Investor stats

  • Total investments: 221
  • Round size: Seed $624k–$11M; Series A $2M–$17M; Series B $2.8M–$20M
  • Lead/follow: 38% lead, 62% follow
  • Last fund: Likely actively investing — fresh fund, raised $326M in 2025

Portfolio highlights

  • Mujin — At Mujin, we design automation platforms to enhance any robot, enable advanced capabilities and lower operating costs.
  • RegCell — RegCell aims to generate novel therapeutic technologies through augmenting or controlling the immune system and our goal is to save patients who suffer from autoimmune diseases and cancer .
  • United Immunity — Just another WordPress site
Show all investments...

Mizuho Capital
VC Fund · Tokyo, Tokyo, Japan · 15 investments in Japan Biotechnology startups

Mizuho is the venture capital firm affiliated to Mizuho Bank, the second-largest Japanese bank in terms of assets. The firm has headquarters in Tokyo. The firm has ¥49.6 billion JPY under management, focusing on information technology and biotechnology investments. Over 600 Mizuho companies have gone public. According to Nikkei, Mizuho is the fifth-largest venture capital firm in Japan. Mizuho Capital was formed in 2002 by the merger of Fujigin Capital, Tokyo Venture Capital and IBJ Investment. Three firms were subsidiaries of Fuji Bank, Dai-Ichi Kangyo Bank and the Industrial Bank of Japan respectively.

Show more...

Investment focus

  • Industry: Information Technology, Software, Artificial Intelligence
  • Stage:Venture - Series Unknown, Series A, Series B
  • Geography: Japan, United States, Singapore

Investor stats

  • Total investments: 564
  • Round size: Series A $1.4M–$32M; Series B $2.4M–$47M; Venture - Series Unknown $581k–$10M
  • Lead/follow: 5% lead, 95% follow
  • Last fund: May invest from a new fund soon — raised $92M in 2020

Portfolio highlights

  • CaTe — CaTe is based in Tokyo. CaTe develops and manufactures a Digital Therapeutic (DTx) for remote cardiac rehabilitation. Their invention allows heart disease patients to safely and successfully complete cardiac rehabilitation utilizing standing exercise in a confined space, such as at home, without the use of ergometers or similar instruments.
  • Flyle — Flyle provides a cloud based platform for product management helping customers to improve productivity & creativity in product development.
  • Crosssector — Crosssector provides sensor DX solutions for various kinds of construction and maintenance applications.
Show all investments...

Keio Innovation Initiative
VC Fund · Tokyo, Tokyo, Japan · 14 investments in Japan Biotechnology startups, 8 in the past 12 months

Keio Innovation Initiative (KII) is a venture capital established by Keio University. In order to make more effective use of the research results of Keio University, we aim to contribute to the development of society by creating investment for venture companies that utilize research results and creating new industries.The key to thinking aboutJapan's future growth strategy is to utilize advanced research results of the university. In addition to GDP, in addition to GDP, Japan is the world's third largest R & D exporter in R & D expenses, but as the low growth rate shows, it has a problem in investment efficiency in research and development. There are also reports on the entrepreneurial spirit that is indispensable for creating new industries, with the lowest entrepreneurial activity rate among developed countries.

Show more...

Investment focus

  • Industry: Health Care, Medical, Biotechnology
  • Stage:Series A, Seed, Venture - Series Unknown
  • Geography: Japan, United Kingdom

Investor stats

  • Total investments: 91
  • Round size: Seed $826k–$14M; Series A $2.2M–$41M; Venture - Series Unknown $1.6M–$12M
  • Lead/follow: 30% lead, 70% follow
  • Last fund: May invest from a new fund soon — raised $94M in 2020

Portfolio highlights

  • ElleThermo — elleThermo aims to implement Semiconductor-Sensitised Thermal Cells (STCs), an energy conversion technology that can generate electricity from unused waste heat above room temperature.
  • Starlight Engine — Starlight Engine develops and commercializes fusion energy power plant technologies.
  • Neusignal Therapeutics — Neusignal Therapeutics is a medical company that develops therapeutic medicines for dementia and psychiatric illnesses.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Real Tech Japan
VC Fund · Sumida, Tokyo, Japan · 11 investments in Japan Biotechnology startups

Real Tech Japan is a venture capital firm that seeks to invest in innovative R&D technology companies. Realtech Fund is a joint venture between the Ministry of Economy, Trade, and Industry and NEDO (New Energy and Industrial Technology Development Organization). The firm was founded in 2014 and based in Tokyo, Japan.

Show more...

Investment focus

  • Industry: Manufacturing, Biotechnology, Robotics
  • Stage:Venture - Series Unknown, Seed, Series A
  • Geography: Japan, Singapore, Austria

Investor stats

  • Total investments: 79
  • Round size: Seed $316k–$5M; Series A $2.1M–$21M; Venture - Series Unknown $421k–$10M
  • Lead/follow: 41% lead, 59% follow
  • Last fund: May invest from a new fund soon — last raise in 2020

Portfolio highlights

  • Ashirase — Ashirase is a developer of a walking navigation system for the visually challenged. The company assists visually impaired people in walking independently. This also allows the user to have more attention to spare for audible warnings in their environment. It includes voice input and guidance via a smartphone app. A vibration interface is attachedto their shoes.
  • Ken Robotec — Ken Robotec provides labor-saving solutions that promote productivity improvement and reduce the burden on workers at construction sites. The company contributes to the evolution and development of the construction industry. The objective of Ken Robotec is to create a joyful construction site where robots and humans may collaborate.
  • MaterialGate — MaterialGate focuses on single-molecule dielectrics, developing technologies for devices with better electronic characteristics.
Show all investments...

Miyako Capital
VC Fund · Kyoto, Kyoto, Japan · 10 investments in Japan Biotechnology startups

Miyako Capital is the venture capital that manages Kyoto University 2nd Venture Fund (KUVF). The company was founded in 2013 and based in Kyoto & Tokyo, Japan. Investment fields are: 1) Life Science, Biotechnology: Drug creation, regenerative medicine, medical beauty equipment, medical services. 2) Agri-Food: Industrialization, agricultural and fishery products growth-promoting technology, specified health food, health food. 3) Environment, Energy: Alternative energy, and related technologies. 4) IT, Electronics: Web, mobile related devices and application, telecommunication technology, security, consumer and business oriented application, mechatronic, robot. 5) New services utilizing state-of-art technology. Investment stages: Primary investment stages are initial-growth stages of seed and early. However, we aim at all growth stages and make investment in post-IPO portfolio companies as well as public companies that are related with Kyoto University.

Show more...

Investment focus

  • Industry: Medical, Biotechnology, Information Technology
  • Stage:Series A, Seed, Series B
  • Geography: Japan, United States, United Kingdom

Investor stats

  • Total investments: 54
  • Round size: Seed $395k–$19M; Series A $2M–$21M; Series B $3.7M–$150M
  • Lead/follow: 19% lead, 81% follow
  • Last fund: May invest from a new fund soon — raised $91M in 2019

Portfolio highlights

  • Mui Lab — Mui is an aesthetically-pleasing wooden IoT device connected to a cloud service. By accessing information through natural wood, we can rethink a new type of lifestyle.
  • Fermelanta — Fermelanta produces rare plant-based ingredients through microbial fermentation. It engineers a cell to build a biosynthetic pathway of target molecules with gene transfer and disruption.
  • United Immunity — Just another WordPress site
Show all investments...

SBI Investment
VC Fund · Minato, Chiba, Japan · 10 investments in Japan Biotechnology startups

SBI Investment supports the business development and growth of private venture companies through fund investment. It manages and manages venture capital funds under the management philosophy of becoming a leading company responsible for the creation and development of core industries in the 21st century as a "new industry creator". SBI Investment has invested in a total of 986 companies in the past, of which 169 (17.1% of investment companies) have exited through IPO or M & A.

Show more...

Investment focus

  • Industry: Software, Information Technology, Financial Services
  • Stage:Series B, Series A, Venture - Series Unknown
  • Geography: Japan, United States, South Korea

Investor stats

  • Total investments: 457
  • Round size: Series A $1.9M–$28M; Series B $4.5M–$62M; Venture - Series Unknown $1.3M–$20M
  • Lead/follow: 27% lead, 73% follow
  • Last fund: May invest from a new fund soon — raised $77M in 2020

Portfolio highlights

  • LQUOM — QWAVE offers cryptography communication technology.
  • Alxtal — Alxtal is a tech company who optimize the development, design, and manufacturing processes of the manufacturing industry with IT and AI.
  • Zerodoor HD — Zerodoor HD specializes in digital transformation in constructing industry.
Show all investments...

DBJ Capital
VC Fund · Otemachi, Tokyo, Japan · 10 investments in Japan Biotechnology startups, 14 in the past 12 months

DBJ Capital Co., Ltd. was founded in June 2010 through the integration of two venture capital firms of the DBJ Group, New Business Investment Co., Ltd. and Intellectual Properties Development & Investment, Inc. We are a wholly-owned subsidiary of Development Bank of Japan Inc. At DBJ Capital, we focus on venture firms which use new technologies and business models to grow and compete on the global market, regardless of their industry or scale. To meet the particular needs of each client, we mobilize the entire DBJ Group to arrange the best investment solutions, ranging from growth-spurring equity investment to financing schemes drawing on DBJ's vast networks. We also assist in venture start-ups. Our value enhancement team provides the kind of comprehensive, hands-on support needed to commercialize outstanding intellectual property and technologies developed by firms, research labs, and universities, and to carve out a place for them in the market. DBJ Capital will continue to play in a part in Japan's economic revival - by helping the firms we invest in to grow, and by encouraging the creation of new industries in Japan.

Show more...

Investment focus

  • Industry: Health Care, Software, Biotechnology
  • Stage:Series A, Venture - Series Unknown, Series B
  • Geography: Japan, United States, Australia

Investor stats

  • Total investments: 176
  • Round size: Series A $2.4M–$17M; Series B $4.6M–$34M; Venture - Series Unknown $976k–$8.8M
  • Lead/follow: 19% lead, 81% follow

Portfolio highlights

  • Facilo — Facilo is a real estate communication provider that uses cloud computing to enhance sales and ease transactions of real estate brokerage.
  • MOT — MOT manages and supports the business activities of writers, particularly manga artists, while also operating “Kakikomi,” an online manga school that provides aspiring artists with education, guidance, and practical training to develop their creative skills.
  • Spectronix — Spectronics is a development of new technologies and new applications to bring about innovation, focusing on the future of laser technology.
Show all investments...

Nissay Capital
VC Fund · Tokyo, Tokyo, Japan · 9 investments in Japan Biotechnology startups

Nissay Capital is a venture capital Company specializing in seed, start-up, growth capital, middle stage, and later stage investment.

Show more...

Investment focus

  • Industry: Health Care, Software, Information Technology
  • Stage:Venture - Series Unknown, Seed, Series A
  • Geography: Japan, United States, Ethiopia

Investor stats

  • Total investments: 349
  • Round size: Seed $455k–$4.5M; Series A $1.2M–$11M; Venture - Series Unknown $899k–$7M
  • Lead/follow: 30% lead, 70% follow
  • Last fund: May invest from a new fund soon — raised $92M in 2019

Portfolio highlights

  • Indent — Indent creates products that help writers create original works such as novels, manga, screenplays, and game scenarios. They will work to create an environment in which artists can focus on their creations and enjoy sharing their work.
  • Spectronix — Spectronics is a development of new technologies and new applications to bring about innovation, focusing on the future of laser technology.
  • Zeal Boxing Fitness — Zeal Boxing Fitness combines power of sports with the power of technology to provide a service that allows to enjoy fitness.
Show all investments...

Japan Science and Technology Agency
VC Fund · Tokyo, Tokyo, Japan · 9 investments in Japan Biotechnology startups, 6 in the past 12 months

Japan Science and Technology Agency is an integrated organization of science and technology that implements science and technology policy in Japan.  It handles many projects, including the government’s Science and Technology Basic Plan and knowledge creation. The European Sustainability School ESSSR is the owner of Japan Science and Technology Agency. Japan Science and Technology Agency undertakes its task in a comprehensive manner. It also works to provide a sound infrastructure of science and technology information and raise awareness and understanding of science and technology-related issues in Japan. Japan Science and Technology Agency is headquartered in Tokyo, Japan.

Show more...

Investment focus

  • Industry: Biotechnology, Medical, Manufacturing
  • Stage:Series A, Seed, Venture - Series Unknown
  • Geography: Japan

Investor stats

  • Total investments: 56
  • Round size: Seed $1.7M–$5M; Series A $2.3M–$15M; Venture - Series Unknown $975k–$9.8M
  • Lead/follow: 23% lead, 77% follow

Portfolio highlights

  • Triorb — The corporate website of TriOrb Inc., revolutionizing production lines with our ball-driven omnidirectional mobility platform.
  • ANRis — ANRis is a hybrid drug discovery venture that develops medicines to provide medical care for patients with cancer and genetic diseases.
  • Solaris — Solaris commercializes, manufactures, and sells soft robotics using pneumatic artificial muscles. Solaris was founded in 2017 and was headquartered in Tokyo, Japan.
Show all investments...

DG Daiwa Ventures
VC Fund · Marunouchi, Tokyo, Japan · 8 investments in Japan Biotechnology startups, 11 in the past 12 months

DG Daiwa Ventures invests in start-up companies with next-generation technology and provides business development support. It is focused on blockchain, xR, AI, security, and BioHealth, as they are likely to be at the foundations of future businesses. In addition to the five core technologies, the fund will also focus on IoT technologies, which often overlap or serve as an application layer.

Show more...

Investment focus

  • Industry: Software, FinTech, Artificial Intelligence
  • Stage:Seed, Series A, Venture - Series Unknown
  • Geography: Japan, United States, India

Investor stats

  • Total investments: 89
  • Round size: Seed $679k–$6M; Series A $3M–$10M; Venture - Series Unknown $367k–$19M
  • Lead/follow: 19% lead, 81% follow
  • Last fund: May invest from a new fund soon — last raise in 2020

Portfolio highlights

  • New Chat — New Chat is a technology company that develops communication software focused on visual and interactive group interactions. The company builds platforms designed to help small, close-knit groups of people share daily experiences through short-form multimedia content. Its primary software automates the creation of collaborative video logs byprompting users for brief, periodic updates throughout the day. By structuring messaging around shared visual moments, the business aims to provide an alternative to traditional text-based group chats and standard social media networking.
  • First Coffee — Discover the best specialty coffee in India with our range of single origin Arabica beans and exclusive merchandise. Shop online at First Coffee for freshly roasted, quality blends.
  • Tellus Global — Tellus Global is a company focused on creating new businesses using satellite data, AI, and software technologies,Its core mission is to make satellite information accessible and useful across industries such as agriculture, environmental conservation, construction, finance, and disaster management.
Show all investments...

Nippon Venture Capital
VC Fund · Tokyo, Tokyo, Japan · 8 investments in Japan Biotechnology startups, 14 in the past 12 months

Nippon Venture Capital ("NVCC"), established in 1996 as one of the few largest Japanese independent venture capital firms, is destined to undertake the unprecedented task of providing full-range venture capital services in cooperation with major Japanese business leaders and leading companies, which have supported and nurtured various new businesses on their own, as well as proactively developing new venture enterprises.

Show more...

Investment focus

  • Industry: Software, Health Care, Information Technology
  • Stage:Venture - Series Unknown, Series A, Series B
  • Geography: Japan, United States, Indonesia

Investor stats

  • Total investments: 218
  • Round size: Series A $1.5M–$35M; Series B $3.3M–$29M; Venture - Series Unknown $457k–$12M
  • Lead/follow: 18% lead, 82% follow
  • Last fund: Likely still investing — raised $15M in 2023

Portfolio highlights

  • Gecipe — Gecipe provides educational content in the virtual world of esports and is a metaverse education company. Their services include esports english, esports english conversation, and esports gym. For inquiries, telephone numbers and physical addresses are available on their website.
  • United Immunity — Just another WordPress site
  • AOI Biosciences — AOI Biosciences is a biotechnology company that creates testing and drug discovery businesses.
Show all investments...

Kyogin Lease & Capital
VC Fund · Kyoto, Kyoto, Japan · 7 investments in Japan Biotechnology startups

Kyogin Lease & Capital is an investment firm that specializes in the leasing, stock and bond investment and public offering consulting.

Show more...

Investment focus

  • Industry: Manufacturing, Medical, Information Technology
  • Stage:Series A, Venture - Series Unknown, Seed
  • Geography: Japan

Investor stats

  • Total investments: 36
  • Round size: Seed $91k–$3.8M; Series A $1.1M–$16M; Venture - Series Unknown $90k–$9M
  • Lead/follow: 8% lead, 92% follow
  • Last fund: May invest from a new fund soon — raised $9M in 2019

Portfolio highlights

  • TSK Corporation — TSK is a manufacturing company that develops organic synthesis technology to supply innovative and long-lasting catalysts to industries. The company develops and manufactures iron catalysts that are used in the production of agrochemicals, semiconductors, and pharmaceuticals, giving enterprises the option of switching from palladium catalysts tomore environmentally friendly iron catalysts.
  • IKOU — IKOU is an inclusive brand for babies and children that creates products valued by all users. The company's featured products include portable seats, bibs, and children's clothing products along with online services.
  • Towing — Towing is an agricultural company that provides farming, manufacturing, and recycling services.
Show all investments...

Miraidoa
VC Fund · Kyoto, Kyoto, Japan · 7 investments in Japan Biotechnology startups, 7 in the past 12 months

Future Venture Capital Co., Ltd. is a venture capital firm specializing in early stage investment. The firm invests in diversified investment in a broad range of industrial sectors. It seeks to invest in Japan. The firm prefers to be the lead investor in its portfolio companies. Future Venture Capital Co., Ltd. was founded in 1998 and is based inKyoto, Japan with offices in Tokyo, Aomori, Iwate, Yamagata, Kanazawa, Mie, Sakai, Kobe, and Ehime.

Show more...

Investment focus

  • Industry: Manufacturing, Health Care, Information Technology
  • Stage:Venture - Series Unknown, Seed, Series A
  • Geography: Japan, United States, Myanmar

Investor stats

  • Total investments: 171
  • Round size: Seed $338k–$5.3M; Series A $1.2M–$11M; Venture - Series Unknown $96k–$4.6M
  • Lead/follow: 17% lead, 83% follow
  • Last fund: May invest from a new fund soon — raised $2.5M in 2020

Portfolio highlights

  • Naorai — Naorai is a food and beverage firm that manufactures wine, beer, spirits, and non-alcoholic beverages.
  • Sinumy — Sinumy develops touchless identity authentication technology and high-speed, high-precision position measurement technology.
  • Dioseve — Dioseve is providing novel possibilities for all life.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Angel Bridge
VC Fund · Tokyo, Tokyo, Japan · 7 investments in Japan Biotechnology startups, 13 in the past 12 months

Angel Bridge is a angel investor groups in Japan and provide high quality and abundant funds to excellent companies.

Show more...

Investment focus

  • Industry: Information Technology, Software, Consulting
  • Stage:Series A, Seed, Series B
  • Geography: Japan

Investor stats

  • Total investments: 78
  • Round size: Seed $648k–$10M; Series A $2.5M–$19M; Series B $6.5M–$47M
  • Lead/follow: 40% lead, 60% follow
  • Last fund: May invest from a new fund soon — raised $10M in 2019

Portfolio highlights

  • Facilo — Facilo is a real estate communication provider that uses cloud computing to enhance sales and ease transactions of real estate brokerage.
  • PeopleX — PeopleX encourages and assists employees in their professional development.
  • Power Laser — Power Laser is a startup company that offers a range of power laser technologies and applications. The company develops high-power laser systems, related components, and software for advanced industrial and scientific applications. Its mission, “Power lasers open the future,” reflects its focus on next-generation photonics and precision laserinnovation for manufacturing and research sectors.
Show all investments...

IT-Farm
VC Fund · Tokyo, Tokyo, Japan · 6 investments in Japan Biotechnology startups

IT-Farm is a venture capital firm which specializes in seed, start-up, and early stage companies. It primarily invests in mobile, big-data, connected car, IoT, OTT service, Helth care, Bio Tech and other IT industries. The firm actively invests in SF bay area and Japan, as well as other geometries including Asia and Europe. We support portfolio companies, especially on the partnership with Japanese enterprises.

Show more...

Investment focus

  • Industry: Software, Health Care, Medical
  • Stage:Seed, Series A, Series B
  • Geography: United States, Japan, Germany

Investor stats

  • Total investments: 136
  • Round size: Seed $1M–$7.5M; Series A $1.6M–$16M; Series B $2.5M–$36M
  • Lead/follow: 10% lead, 90% follow
  • Last fund: May invest from a new fund soon — last raise in 2021

Portfolio highlights

  • Ubitus — As cloud gaming enablers, Ubitus' GPU virtualization, Streaming technology and hybrid cloud deployment can serve different kinds of solutions for Telco, Game companies to quick enter cloud gaming market. Moreover, Ubitus provide Global distribution and New Media content solution for new media studio and fashion brand to help them distribute rich media contents worldwide.
  • POPS Worldwide — POPS Worldwide is the leading digital entertainment company in Southeast Asia. With over 4 billion monthly views of its music and entertainment content, POPS is the fastest growing digital entertainment media company with hundreds of artists, content creators and partners from broadcast television, publishing and production in the POPS Network.POPS also produces a wide variety of original content for its industry-leading owned and operated channels like POPS Music, POPS Kids, POPS TV, Beauty Me, HerVoice and CoolTV that target highly sought after demographics: teens, kids, women and men.
  • Global Equipment Services — As a strategic partner to developers of multi-sector products, Averna provides innovative automated testing tool and quality assurance solutions.
Show all investments...

Senshu Ikeda Capital
VC Fund · Osaka, Osaka, Japan · 6 investments in Japan Biotechnology startups

Senshu Ikeda Capital offers financial consultancy services.

Show more...

Investment focus

  • Industry: Software, Manufacturing, Internet
  • Stage:Venture - Series Unknown, Series A, Seed
  • Geography: Japan

Investor stats

  • Total investments: 68
  • Round size: Seed $395k–$3.8M; Series A $1.9M–$17M; Venture - Series Unknown $443k–$10M
  • Lead/follow: 4% lead, 96% follow
  • Last fund: May invest from a new fund soon — raised $11M in 2019

Portfolio highlights

  • JiMED — JiMED designs & develops AI based brain-computer interface for implant in ALS patients to improve communication.
  • Molmir — Molmir is a biotech company that conducts research and develops treatments for intractable diseases based on sensing technology.
  • Eight Knot — Eight Knot is a developer of autonomous navigation systems intended for water mobility. They provide autonomous ship maneuvering technology using robotics, enabling customers with water-on-demand transportation using environment-friendly EV robotic boats.
Show all investments...

JIC Venture Growth Investments
VC Fund · Marunouchi, Tokyo, Japan · 5 investments in Japan Biotechnology startups

JIC-VGI helps promote innovation and improve its international competitiveness through growth-investments in startup companies. The firm accelerating innovation and helping to solve industrial and social issues by supporting and seeking innovative technologies and new businesses. JIC Venture Growth Investments was established in July 2020 and is based in Tokyo, Japan.

Show more...

Investment focus

  • Industry: Information Technology, Medical, Software
  • Stage:Series B, Series C, Series A
  • Geography: Japan, United States, Singapore

Investor stats

  • Total investments: 113
  • Round size: Series A $3.1M–$63M; Series B $4.1M–$52M; Series C $4.3M–$77M
  • Lead/follow: 39% lead, 61% follow
  • Last fund: May invest from a new fund soon — raised $1.1B in 2020

Portfolio highlights

  • CaTe — CaTe is based in Tokyo. CaTe develops and manufactures a Digital Therapeutic (DTx) for remote cardiac rehabilitation. Their invention allows heart disease patients to safely and successfully complete cardiac rehabilitation utilizing standing exercise in a confined space, such as at home, without the use of ergometers or similar instruments.
  • QibiTech — QibiTech created HATS, a service in which a human operator remotely supplements the operation of a robot. Add-on edge calculator or software for various robots to increase robot flexibility. It also serves as a platform for connecting operation data to the business improvement system.
  • FLUX — FLUX provide “FLUX Header Bidding Solution” that creates fair competition opportunities and significantly increases advertising revenue within the header bidding server, ad requests are sent to SSPs and ad exchanges all at once, so it is possible to have a pure price competition without prioritization, and to determine the highest bid amount andvalue of the advertising space. I can. Then, the price of the highest bid ad in the header bidding and the ad set in the ad server are competed, and the ad with the higher bid is delivered.
Show all investments...

F-Prime
VC Fund · Cambridge, Massachusetts, United States · 5 investments in Japan Biotechnology startups

F-Prime Capital is a global venture capital firm investing in healthcare and technology, with a heritage that spans four decades.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical
  • Stage:Series A, Series B, Seed
  • Geography: United States, China, United Kingdom

Investor stats

  • Total investments: 558
  • Round size: Seed $1.6M–$20M; Series A $8M–$90M; Series B $15M–$112M
  • Lead/follow: 25% lead, 75% follow

Portfolio highlights

  • Innovent Biologics — Innovent Biologics, Inc. is a privately held biopharmaceutical company that is dedicated to the development and manufacturing of monoclonal antibodies to be marketed in China and elsewhere around the world. Innovent is funded by the venture arm of Fidelity, which is a major investment firm in the US, Lilly Ventures, and Suzhou bioBay. Theregistered capital is 30Million US Dollars. The founders and senior management team of Innovent have over 70 years of combined work experience in the discovery, development and manufacture of biologics in the US, Europe and worldwide and were involved in the launch of such products as Bexxar, Conbercept, Natrecor, Oncorine, Recombivax HB, and others.
  • PlasmaGen Biosciences — PlasmaGen BioSciences is an Indian Bio-pharmaceutical organization specializing exclusively in Plasma Protein Therapy.Headquartered in Bangalore- India, PlasmaGen has been making every effort in the domain of Plasma product Industry and has become an Imperative one stop destination for the medical fraternity for most of the plasma products need.They have a basket of plasma products and the widest range of immunoglobulins in India catering to the requisites of various realms viz. Haematology, Oncology, Immunology, Paediatrics, Rheumatology, Dermatology and Neurology.
  • Ultragenyx Pharmaceutical — Ultragenyx is focused on developing first-ever approved treatments for rare and ultrarare diseases and moving the rare disease community forward.
Show all investments...

Global Brain Corporation
VC Fund · Tokyo, Tokyo, Japan · 5 investments in Japan Biotechnology startups

Global Brain Corporation is a venture capital firm that invests in companies from seed or early to pre-IPO startups. Global Brain has invested in 300+ startups from seed/early to pre-IPO startups and achieved 25 IPOs and 61 M&As as a result of providing hands-on support services and resources to its portfolio startups. Global Brain has managed a pure investment fund as well as multiple corporate venture capital funds partnered together with tier 1 public companies of telecom, real estate development, financial service, beverages, agriculture food, logistics, and electronic devices.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Information Technology
  • Stage:Series A, Series B, Venture - Series Unknown
  • Geography: Japan, United States, South Korea

Investor stats

  • Total investments: 858
  • Round size: Series A $1.9M–$28M; Series B $3.4M–$48M; Venture - Series Unknown $516k–$10M
  • Lead/follow: 30% lead, 70% follow
  • Last fund: Likely actively investing — fresh fund, raised $65M in 2025

Portfolio highlights

  • Josys — Stop letting runaway SaaS costs & unsecured SaaS access ruin your day. Josys is the only SaaS Management Platform that provides true 360-degree control.
  • LIFESCAPES — LIFESCAPES is a research and manufacturer of brain-computer interface equipment.
  • Deeping Source — Real-time Video Analytics based on Data Anonymization. High-accuracy computer vision for large-scale spaces: hypermarkets, shopping malls, convention centers, hospitals, logistics warehouses, construction sites, etc.
Show all investments...

D3
VC Fund · Tokyo, Tokyo, Japan · 5 investments in Japan Biotechnology startups

DISCOVERY, DEVELOPMENT, DEPLOYMENT FOR GLOBAL HEALTH, WITH SCIENCE & BUSINESS ACUMEN

Show more...

Investment focus

  • Industry: Biotechnology, Therapeutics, Manufacturing
  • Stage:Series A, Seed, Series B
  • Geography: Japan, United States

Investor stats

  • Total investments: 12
  • Round size: Seed $1.6M–$2.8M; Series A $690k–$51M
  • Lead/follow: 58% lead, 42% follow

Portfolio highlights

  • Neumo — Neumo is a musical education-based firm that offers pitch measurement courses, programs, consulting, and tests.
  • RevolKa — RevolKa manufactures bio-products pharmaceuticals intended to serve the healthcare sector.
  • Neros Technologies — Neros is vertically integrating production of unmanned defense systems in the United States, securing the autonomous supply chain. Are you with us?
Show all investments...

FFG Venture Business Partners
VC Fund · Fukuoka, Fukuoka, Japan · 5 investments in Japan Biotechnology startups

FFG Venture Business Partners is a large-scale enterprise that offers in traditional regional bank venture capital.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Health Care
  • Stage:Series A, Venture - Series Unknown, Seed
  • Geography: Japan, Indonesia, United States

Investor stats

  • Total investments: 89
  • Round size: Seed $706k–$50M; Series A $1.2M–$8.4M; Venture - Series Unknown $547k–$10M
  • Lead/follow: 10% lead, 90% follow
  • Last fund: May invest from a new fund soon — raised $46M in 2020

Portfolio highlights

  • Josan-shes — Josan shes is web start up that offers nursing service to women and babies.
  • InsightX — InsightX is a technology platform focused on empowering businesses by simplifying complex processes and enabling smarter, more personalized user experiences.
  • DeltaForesight — DeltaForesight is a business that creates B2B services and goods with a focus on stablecoins and cryptocurrencies. In order to develop solutions that may be applied in Japan, it emphasizes bridging laws, business practices, and technological advancements.
Show all investments...

Delight Ventures
VC Fund · Shibuya, Kanagawa, Japan · 4 investments in Japan Biotechnology startups, 18 in the past 12 months

Delight Ventures is a venture capital firm that thoroughly reduces the hurdles of entrepreneurship in Japan and supports entrepreneurs in the world. Entrepreneurship is taken as a natural career path, and we aim to be a society where both successful and unsuccessful people can continue to take on challenges.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Information Technology
  • Stage:Seed, Series A, Series B
  • Geography: Japan, United States, Malaysia

Investor stats

  • Total investments: 93
  • Round size: Seed $556k–$4.3M; Series A $1.9M–$11M; Series B $3.1M–$19M
  • Lead/follow: 31% lead, 69% follow
  • Last fund: May invest from a new fund soon — raised $93M in 2019

Portfolio highlights

  • 10pct. — 10pct. is a consulting firm that provides hotel management, marketing, and operation support services to its clients.
  • Ocean — Ocean is a technology-driven company dedicated to promoting digital transformation in the tax-free and retail shopping sectors. By developing innovative digital platforms and integrated solutions, the company streamlines tax refund processes and enhances the overall shopping experience for international travelers and retailers alike.
  • Voxela, Inc. — Voxels is an AI powered platform on a mission to reinvent caregiving by making incident detection intelligent and actionable.
Show all investments...

Incubate Fund
VC Fund · Tokyo, Tokyo, Japan · 4 investments in Japan Biotechnology startups

Incubate Fund is an independent early-stage venture capital that specializes in providing capital to technology startups at the seed stage. The firm built a portfolio of over 300 companies in Asia, taking 12 companies to public and 20 companies to M&A exit since 2010.

Show more...

Investment focus

  • Industry: Software, Information Technology, Artificial Intelligence
  • Stage:Seed, Series A, Venture - Series Unknown
  • Geography: Japan, United States, India

Investor stats

  • Total investments: 414
  • Round size: Seed $289k–$7M; Series A $1.5M–$20M; Venture - Series Unknown $368k–$8.1M
  • Lead/follow: 33% lead, 67% follow
  • Last fund: Likely still investing — raised $127M in 2024

Portfolio highlights

  • Akari Hosho — Akari Hosho provides a group of trusted professionals, including lawyers and judicial scriveners. Akari Hosho provides a guarantee service.
  • Black Cat Carnival — Tell us about anything development-related. Our founder, who launched Niconico Live, SUGAR and GANMA! from scratch, helps with planning, design, development and operations.
  • Carbon CryoCapture — Carbon CryoCapture specializes in the carbon dioxide separation systems aimed at creating economically viable, energy-efficient, and genuinely sustainable CO2 separation and recovery technologies. The company is dedicated to deploying cost-effective, efficient systems for CO2 capture that integrate smoothly with current infrastructures, all whileenhancing energy consumption and production. This enables clients to attain zero emissions throughout the development and application of resources.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Innovation Network Corporation of Japan
VC Fund · Tokyo, Tokyo, Japan · 4 investments in Japan Biotechnology startups

Innovation Network Corporation of Japan (INCJ) is a public-private partnership aimed at promoting innovation and enhancing value. Leveraging the rich history of Japanese technological prowess, INCJ aims to provide financial, technological and management support in order to promote the creation of next-generation businesses through “open innovation,” or the flow of technology and expertise beyond the boundaries of existing organizational structures. INCJ will draw on funding as well as management and technological expertise from the public and private sectors. INCJ is actively reviewing various investment opportunities in areas of green energy, electronics, IT and biotechnology to infrastructure-related sectors such as water supply. Each investment will be thoroughly vetted to ensure it meets the exacting standards of INCJ's Innovation Network Committee, which will make the final investment decisions. INCJ is capitalized at 280 billion yen, with the Japanese government injecting 266 billion yen and 26 private corporations (refer to details in Appendix below) providing a further 14 billion yen. The government will also provide guarantees up to a total of 1,800 billion yen for INCJ investments, giving it an investment capability of approximately 2,000 billion yen. INCJ will be established for a period of 15 years.

Show more...

Investment focus

  • Industry: Manufacturing, Software, Medical
  • Stage:Venture - Series Unknown, Series B, Series A
  • Geography: Japan, United States, United Kingdom

Investor stats

  • Total investments: 187
  • Round size: Series A $4.3M–$71M; Series B $4.8M–$156M; Venture - Series Unknown $2.5M–$22M
  • Lead/follow: 41% lead, 59% follow

Portfolio highlights

  • Cloudian — Cloudian provides exabyte-scale storage for your capacity-intensive workloads: S3-compatible storage for on-prem, hybrid cloud, and multi-cloud.
  • Seajacks — Cadeler is a global leader in offshore wind farm construction, maintenance, and decommissioning.
  • Vehicle Energy Japan — Vehicle Energy Japan specializes in development, manufacturing and sales of automotive lithium-ion batteries.
Show all investments...

SBI Group
VC Fund · Tokyo, Tokyo, Japan · 4 investments in Japan Biotechnology startups, 25 in the past 12 months

SBI Group aims to become a corporate entity that provides a variety of one-stop financial services over the Internet now that two major events, the Financial Big Bang resulting from deregulation, and the Internet Revolution resulting from IT innovation, have radically transformed the financial industry.

Show more...

Investment focus

  • Industry: Financial Services, FinTech, Finance
  • Stage:Series A, Series B, Series C
  • Geography: Japan, United States, United Kingdom

Investor stats

  • Total investments: 173
  • Round size: Series A $2.8M–$62M; Series B $7M–$54M; Series C $13M–$134M
  • Lead/follow: 47% lead, 53% follow

Portfolio highlights

  • GeoDreams — GeoDreams is a clean energy and geothermal technology company focused on next-generation closed-loop geothermal power generation.
  • PhotonPay — Founded in 2015, PhotonPay is a digital financial infrastructure provider offering global payment solutions to businesses. Our innovative core products include Global Accounts, Card Issuing, Online Payments, Payouts, FX Management and Embedded Finance. PhotonPay has become a Mastercard issuer in Hong Kong and the fintech card issuer in the GreaterChina region of Discover® Network. With a strong compliance culture and technological innovation capabilities, PhotonPay is building a digital payment network to take the friction out of global payments and enhance operational efficiency for businesses operating on a global scale. Headquartered in Hong Kong and providing localized services through nine international offices, PhotonPay partners with a network of top-tier banks and global financial institutions and serves more than 200,000 customers globally.
  • Evernorth — Evernorth is a purpose-built digital asset treasury that gives investors exposure to tomorrow’s markets. The company focuses on XRP, using XRP Ledger infrastructure, DeFi, liquidity, and yield strategies. The company also develops treasury strategies to generate returns from its digital asset holdings.
Show all investments...

Remiges Ventures
VC Fund · Cambridge, Massachusetts, United States · 4 investments in Japan Biotechnology startups

Remiges Ventures is a venture capital firm that focuses on groups and businesses in the Japanese academia and pharmaceutical industry.

Show more...

Investment focus

  • Industry: Biotechnology, Medical, Health Care
  • Stage:Series A, Series B, Seed
  • Geography: United States, Japan, Canada

Investor stats

  • Total investments: 25
  • Round size: Seed $2.6M–$10M; Series A $6.8M–$25M; Series B $8.2M–$41M
  • Lead/follow: 64% lead, 36% follow
  • Last fund: May invest from a new fund soon — raised $95M in 2019

Portfolio highlights

  • Kupando — Kupando is a biopharmaceutical company that develops agonists to stimulates innate immunity.
  • Glycomine — We are developing a PMM2-CDG substrate replacement therapy. GLM101 is a mannose-1 phosphate treatment.
  • Restore Vision — Restore Vision is a startup based in Japan aiming to develop a visual restoration gene therapy.
Show all investments...

Fujifilm
VC Fund · Tokyo, Tokyo, Japan · 4 investments in Japan Biotechnology startups

Fujifilm develops and sells consumer products and business products related to photography. Fujifilm Holdings Corporation is a Japanese multinational photography and imaging company. The company serves various industries, including medical, graphic arts, optics, enterprise storage, motion picture, and photography.The company’s consumer productsare categorized as digital cameras and accessories, film photography, Instax photography, and binoculars. Its business products are categorized as medical systems, Fujinon endoscopy, microfilm, data storage, graphic arts and printing, professional video, optical devices, specialty chemicals, printing imaging colorants, and more. Color films, digital cameras, photofinishing equipment, color papers, photofinishing chemicals, medical imaging equipment, graphic arts equipment and materials, flat panel displays, and photocopiers and printers are some products developed by Fujifilm USA.Fujifilm USA is based in Minato-ku, Tokyo, Japan.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series A, Venture - Series Unknown, Corporate Round
  • Geography: Japan, United States, China

Investor stats

  • Total investments: 25
  • Round size: Series A $3.3M–$250M; Corporate Round $1.3M–$1.7B; Venture - Series Unknown $2.9M–$36M
  • Lead/follow: 28% lead, 72% follow

Portfolio highlights

  • Ripcord — Ripcord turns documents into powerful data. As a disruptor in the document intelligence market, Ripcord’s AI-driven platform harnesses proprietary robotics, generative AI, and cloud software to digitize and accurately derive vital information from paper and digital documents. Founded out of NASA research, Ripcord is backed by leading investorsincluding Kleiner Perkins, Google Ventures, Icon Ventures, Lux Capital, MUIP, and Apple co-founder Steve Wozniak.
  • Rapidus — Rapidus is an Electronic component research, development, design, production, and sales that includes semiconductor elements and integrated circuits. Environmentally friendly, energy-saving semiconductors and semiconductor manufacturing technology are being researched and developed. Human resource development and training for the semiconductorsector.
  • VALANX Biotech — VALANX Biotech is a site-specific protein conjugation platform to enable fast and cost efficient protein-drug-conjugates development.
Show all investments...

Tsukuba Institute of Research
VC Fund · Ibaraki, Osaka, Japan · 4 investments in Japan Biotechnology startups

Tsukuba Institute of Research (筑波総研) is an R&D center owned by housing and wood products group Sumitomo Forestry. The facility develops technologies to make more effective use of wood in a wide range of fields.

Show more...

Investment focus

  • Industry: Medical, Manufacturing, Health Care
  • Stage:Series A, Seed
  • Geography: Japan

Investor stats

  • Total investments: 10
  • Round size: Seed $953k–$1.8M; Series A $2M–$7.1M
  • Lead/follow: 10% lead, 90% follow
  • Last fund: May invest from a new fund soon — raised $4.5M in 2019

Portfolio highlights

  • LIGHTz — LIGHTz delivers a technology transfer and information exchange platform leveraging AI.
  • Celaid Therapeutics — Celaid Therapeutics develops technologies and products based on hematopoietic stem cell (HSC) expansion and gene-augmented therapies. The company operates a platform that enables in-vitro propagation of human HSCs without relying on animal-derived components, facilitating scalability, consistency, and cost control. It applies this platform acrossworkflows, including donor/patient cell collection, HSC expansion, cell processing, and gene editing to deliver cell therapy products. Celaid advances pipelines in areas such as blood cancers, genetic disorders, and rare hematologic diseases. Through partnerships and internal research, it seeks to support both reagent/media supply and therapeutic development around HSC-based regenerative medicine.
  • Veneno Technologies — Veneno Technologies develops drug candidates for pharmaceutical companies. The company provides services that include the treatment of neurological, cardiovascular, and metabolic diseases, cancer cell proliferation, metastasis, and immune cell regulation.
Show all investments...

Eight Roads Ventures
VC Fund · London, England, United Kingdom · 4 investments in Japan Biotechnology startups

Eight Roads has a 50+ year history of investing and partners with game-changing technology and healthcare companies, supporting them as they scale to become global leaders.

Show more...

Investment focus

  • Industry: Health Care, Software, Biotechnology
  • Stage:Series B, Series A, Series C
  • Geography: United States, China, India

Investor stats

  • Total investments: 504
  • Round size: Series A $6M–$50M; Series B $9.4M–$70M; Series C $10M–$117M
  • Lead/follow: 42% lead, 58% follow
  • Last fund: Likely still investing — raised $350M in 2022

Portfolio highlights

  • GoodData.AI — GoodData is a leading composable data and analytics platform. Build, embed, and scale analytics on demand, with zero vendor lock-in.
  • specsmakers — Buy Eyeglasses, Eyeglass Frames, Computer Glasses, Contact Lenses, Sunglasses online at Specsmakers. Latest Collection of Frames. Free Shipping. Secure checkout. 14 Days Return Policy.
  • PlasmaGen Biosciences — PlasmaGen BioSciences is an Indian Bio-pharmaceutical organization specializing exclusively in Plasma Protein Therapy.Headquartered in Bangalore- India, PlasmaGen has been making every effort in the domain of Plasma product Industry and has become an Imperative one stop destination for the medical fraternity for most of the plasma products need.They have a basket of plasma products and the widest range of immunoglobulins in India catering to the requisites of various realms viz. Haematology, Oncology, Immunology, Paediatrics, Rheumatology, Dermatology and Neurology.
Show all investments...

Daiwa Corporate Investment
VC Fund · Tokyo, Tokyo, Japan · 4 investments in Japan Biotechnology startups

Daiwa Corporate Investment is a private investment firm of Daiwa Securities Group that has been engaged in overseas VC investments by taking advantage of an extensive business network in Japan and foreign countries, long experience and professional knowledge, and by supporting the growth of a number of overseas portfolio companies and their stock exchange listings.

Show more...

Investment focus

  • Industry: Software, Manufacturing, Health Care
  • Stage:Venture - Series Unknown, Series A, Seed
  • Geography: Japan, United States, France

Investor stats

  • Total investments: 145
  • Round size: Seed $310k–$1.3M; Series A $1.1M–$6.9M; Venture - Series Unknown $910k–$9.2M
  • Lead/follow: 19% lead, 81% follow
  • Last fund: May invest from a new fund soon — raised $90M in 2018

Portfolio highlights

  • NovAccel — NovAccel operates as a deep tech company, ensure a stable supply of medical radioisotopes.
  • AstroX — AstroX is a private space startup company that develops satellite launch vehicles for space development. It utilizes the rockoon method for developing launch vehicles and small rockets to help clients easily use space.
  • Sonire Therapeutics — SONIRE Therapeutics Inc. (SONIRE) is working on a next-generation high-intensity focused ultrasound (HIFU) therapy system that will employ acoustic engineering (ultrasound) technologies developed through cutting-edge academic research. SONIRE has been working on a next-generation high-intensity focused ultrasound (HIFU) treatment system as a noveltherapeutic modality with the goal of giving cancer patients and their families a new future.
Show all investments...

Capital Medica Ventures
VC Fund · Tokyo, Tokyo, Japan · 4 investments in Japan Biotechnology startups

Capital Medica Ventures is a venture capital firm based in Tokyo, Japan with a focus on startups in the healthcare industry.Capital Medica Ventures is a venture capital that operates a venture fund specializing in the healthcare field. It is the only healthcare-specialized VC in Japan that can provide 30 medical institutions as a business trialfield.

Show more...

Investment focus

  • Industry: Health Care, Medical, Software
  • Stage:Seed, Series A, Venture - Series Unknown
  • Geography: Japan

Investor stats

  • Total investments: 19
  • Round size: Seed $91k–$1.1M; Series A $1.5M–$51M; Venture - Series Unknown $1.5M–$11M
  • Lead/follow: 16% lead, 84% follow
  • Last fund: May invest from a new fund soon — raised $12M in 2018

Portfolio highlights

  • A-SEEDS — A-SEEDS, an innovative biotech company sprouted from Shinshu University, is dedicated to pioneering advanced treatments for life-threatening cancers. Harnessing the potential of non-viral genetic engineering, our cutting-edge immune cell therapy opens up new horizons of hope for patients seeking effective and transformative solutions.
  • Do. Sukasu — Do. Sukasu is a software company that specializes in the development of visual space perception ability for brain science approaches.
  • HEAL-lll — HEAL-lll is a multifaceted firm that merges healthcare, technology, and gamification to promote individual and organizational well-being.
Show all investments...

QB Capital
VC Fund · Fukuoka, Fukuoka, Japan · 3 investments in Japan Biotechnology startups

QB Capital is make equity investments in venture companies.

Show more...

Investment focus

  • Industry: Manufacturing, Medical, Biotechnology
  • Stage:Seed, Series A
  • Geography: Japan, Singapore, United States

Investor stats

  • Total investments: 54
  • Round size: Seed $641k–$35M; Series A $1.3M–$213M
  • Lead/follow: 22% lead, 78% follow
  • Last fund: May invest from a new fund soon — raised $429M in 2015

Portfolio highlights

  • Equmenopolis — We dispatch conversational AI agents to schools and workplaces to improve creativity and productivity.
  • Mechano Cross — Mechano Cross is a mechanical company that offers mechanochemical organic synthesis technology for solution reactions.
  • Surv Biopharma — Surv Biopharma develops a drug discovery platform that facilitates research and development of veterinary drugs and pharmaceutical products.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Sosei CVC
VC Fund · Tokyo, Tokyo, Japan · 3 investments in Japan Biotechnology startups

Sosei CVC is support the creation and growth of life science companies.

Show more...

Investment focus

  • Industry: Biotechnology, Medical, Pharmaceutical
  • Stage:Series A, Series B
  • Geography: Japan

Investor stats

  • Total investments: 7
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Junten Bio — JUNTEN BIO is a company is to develop new technologies in the field of regenerative medicine.
  • Chromocenter — Chromocenter is a next generation biopharmaceuticals Manufacturing company. It uses technologies such as artificial chromosome vectors, mainly for drug discovery such as medical pharmaceuticals
  • Noile-Immune Biotech — Neurymune Biotech Co., Ltd. is a national cancer research center specializing in the development of cancer immunotherapies based on CAR-T cell therapy and a venture company from Yamaguchi University. They aim to be a leading company responsible for the next generation in the field of cancer immunotherapy.
Show all investments...

Universal Materials Incubator
VC Fund · Tokyo, Tokyo, Japan · 3 investments in Japan Biotechnology startups

Universal Materials Incubator Co., Ltd. is venture capital firm specializing in materials and chemical industry investments. The firm was established on October, 2015 and is headquartered in Tokyo, Japan

Show more...

Investment focus

  • Industry: Manufacturing, Biotechnology, Chemical
  • Stage:Series A, Series B
  • Geography: Japan, United States, India

Investor stats

  • Total investments: 38
  • Round size: Series A $2M–$17M; Series B $2.8M–$99M
  • Lead/follow: 39% lead, 61% follow
  • Last fund: May invest from a new fund soon — raised $1.3B in 2019

Portfolio highlights

  • Polyuse — Polyuse Co., Ltd. is developing technology centered on "3D printers for construction" for the construction and civil engineering industries under the mission of "updating the construction industry with the power of technology".
  • EF Polymer — EF Polymer Private Limited providing 100% Organic and fully Biodegradable Super Absorbent Polymer cum Fertilizer to reduce Water and Fertilizer requirement for your plant. Let's grow organically.
  • Fermelanta — Fermelanta produces rare plant-based ingredients through microbial fermentation. It engineers a cell to build a biosynthetic pathway of target molecules with gene transfer and disruption.
Show all investments...

WASEDA University Ventures
VC Fund · Tokyo, Tokyo, Japan · 3 investments in Japan Biotechnology startups

WASEDA University Ventures (WUV) is a venture capital firm specialising in founding investments by creating new start-up companies that make use of academia and are based on "the practical application of scholarship". Our mission is to be a capitalist that implements academic knowledge and

Show more...

Investment focus

  • Industry: Medical, Biotechnology, Information Technology
  • Stage:Seed, Series A, Convertible Note
  • Geography: Japan, United States, United Kingdom

Investor stats

  • Total investments: 13
  • Round size: Seed $1.2M–$38M; Series A $1.3M–$14M
  • Lead/follow: 38% lead, 62% follow

Portfolio highlights

  • Neubond — Neubond develops wearable devices for stroke mobility rehabilitation. These devices provide autonomous assistance and therapy during daily activities, integrating rehabilitation into the patient's daily life regardless of their motor capabilities. Neubond's solutions are designed to be intuitive and effective, aiming to improve thequality of life for individuals undergoing rehabilitation.
  • Pestalozzi Technology — Pestalozzi Technology is a development and provision of educational products in the fields of physical education and club activities.
  • Gel-Coat Biomaterials — Gel-Coat Biomaterials is a biotechnology company that develops innovative bio-based materials and new medical technologies.
Show all investments...

NEDO
VC Fund · Kawasaki, Kanagawa, Japan · 3 investments in Japan Biotechnology startups, 10 in the past 12 months

New Energy and Industrial Technology Development Organization (NEDO) was established as a governmental organization in 1980 to promote the development and introduction of new energy technologies. Research and development of industrial technology was later added, and today NEDO is active in a wide variety of areas as one of the largest public research and development management organizations in Japan.

Show more...

Investment focus

  • Industry: Medical, Health Care, Biotechnology
  • Stage:Grant, Series A, Seed
  • Geography: Japan, United States

Investor stats

  • Total investments: 45
  • Round size: Seed $885k–$991k; Grant $1.7M–$26M; Series A $800k–$4.7M
  • Lead/follow: 62% lead, 38% follow

Portfolio highlights

  • SACMOTs — SACMOTs is developing technologies that accelerate crop growth from the seed stage, reducing the time to harvest. By enabling more cultivation cycles each year with the same equipment, it aims to improve the productivity and profitability of plant factories.
  • Taskaji — TASKAJI is an online housekeeping service that matches people looking for someone to do their housekeeping with those who want to work as housekeepers.The companies motto is of “from the nuclear family to the extended family” and it aims to provide people with more leisure time through its concept of “housekeeping sharing.
  • BEAM Technologies — BEAM Technologies, focuses on developing optical semiconductor devices using special light to offer clean solutions to ecosystem-related problems.
Show all investments...

Euglena
VC Fund · Tokyo, Tokyo, Japan · 3 investments in Japan Biotechnology startups

euglena Co., Ltd. engages in the research, development, production, and sale of microalgae with a focus on euglena. The company also manufactures and sells foods and cosmetics using euglena. It offers green juices, cookie bars, beverages, dietary supplements, and raw materials, as well as contract manufacturing/processing services; and skincare products.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Food and Beverage
  • Stage:Seed, Series A, Venture - Series Unknown
  • Geography: Japan, United States

Investor stats

  • Total investments: 10
  • Round size: Seed $527k–$3.7M; Series A $2.2M–$5.6M
  • Lead/follow: 20% lead, 80% follow

Portfolio highlights

  • KAICO — KAICO is a pharmaceuticals, diagnostic drugs production company.
  • Misaky Tokyo — Marine plant-based, handmade Japanese sweets. These crystal treats are individually handcrafted, the perfect gift idea! Vegan, gluten-free, and additive-free confectionery, with stunning flavors such as Yuzu, Matcha, and Rose. Supporting artisans in their craft. Japanese luxury sweets with a surprise inside.
  • Minimal - Bean to Bar Chocolate — Minimal - Bean to Bar Chocolate sells cacao beans and handmade chocolate. Their product line includes chocolate rare cheesecake, cacao tours, chocolate bars, sweets, chocolate sandwich cookies, and sweets. Their products serve consumers.
Show all investments...

STRIVE
VC Fund · Tokyo, Tokyo, Japan · 3 investments in Japan Biotechnology startups

STRIVE focuses on investing in early-stage (Seed to Series A) internet and mobile companies. It seeks out companies in Japan, Southeast Asia, and India with top-notch management teams and strong market potential. It is not tied to strategic investments for GREE Inc. and leverages its pan-Asia expertise for guiding its portfolio in an engaged, hands-on role.

Show more...

Investment focus

  • Industry: Software, E-Commerce, Internet
  • Stage:Seed, Series A, Series B
  • Geography: Japan, India, Indonesia

Investor stats

  • Total investments: 164
  • Round size: Seed $500k–$4.6M; Series A $1.2M–$14M; Series B $3.2M–$25M
  • Lead/follow: 32% lead, 68% follow
  • Last fund: May invest from a new fund soon — raised $10B in 2019

Portfolio highlights

  • ASUENE — Asuene involves in clean power retail business, retail SaaS business, etc.
  • Recompound — Nasihat investasi dari Budi Ryan, Penasihat Investasi berizin dan diawasi OJK. Dana tetap di rekening sekuritas atas nama kamu sendiri; fee saat porto menembus titik tertinggi baru.
  • Testsigma — Powerful cloud-based test automation platform that lets you automate tests for web, mobile, desktop apps, and APIs in minutes. Sign up now!
Show all investments...

Chugin Capital Partner
VC Fund · Okayama, Okayama, Japan · 3 investments in Japan Biotechnology startups

Chugin Capital Partner is a venture capital firm that invests in startups and business succession.

Show more...

Investment focus

  • Industry: Manufacturing, Software, Information Technology
  • Stage:Series A, Seed, Series B
  • Geography: Japan

Investor stats

  • Total investments: 30
  • Round size: Seed $246k–$7.1M; Series A $1.2M–$4M; Series B $1.3M–$54M
  • Lead/follow: 7% lead, 93% follow

Portfolio highlights

  • KG Motors — KG Motors is an automotive firm that manufactures electric vehicles that can be moved comfortably and safely by one person.
  • SoVa — SoVa operates an accounting firm that combines technology and experts.
  • Waku — Waku is a manufacturing company that specializes in the research and development of organic fertilizers for the agriculture industry.
Show all investments...

Antler
VC Fund · Singapore, Central Region, Singapore · 3 investments in Japan Biotechnology startups

Build your next company with Antler, a global day zero investor enabling exceptional founders to start great companies, from the very beginning. Apply now!

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Information Technology
  • Stage:Pre-Seed, Seed, Series A
  • Geography: United States, Singapore, Australia

Investor stats

  • Total investments: 2387
  • Round size: Seed $158k–$4.6M; Pre-Seed $100k–$600k; Series A $4.1M–$29M
  • Lead/follow: 43% lead, 57% follow
  • Last fund: Likely actively investing — fresh fund, raised $7.5M in 2026

Portfolio highlights

  • iiba — Iiba is a geospatial platform that specializes in providing location information related to child-rearing.
  • Obud — Obud is a wellness reservation systems that is designed for holistic health and lifestyle management purposes. The company's systems offer a comprehensive suite of tools for booking wellness activities, managing schedules, and accessing curated wellness programs, enabling wellness centers to streamline their operations, enhance userengagement, and promote a balanced and healthy lifestyle.
  • Plouton AI —
Show all investments...

Higin Capital
VC Fund · Kumamoto, Kumamoto, Japan · 3 investments in Japan Biotechnology startups

Higegin Capital is a venture capital firm.

Show more...

Investment focus

  • Industry: Medical, Biotechnology, Software
  • Stage:Series A, Series B, Venture - Series Unknown
  • Geography: Japan

Investor stats

  • Total investments: 27
  • Round size: Series A $1.2M–$9.1M; Series B $3.8M–$17M; Venture - Series Unknown $279k–$13M
  • Lead/follow: 4% lead, 96% follow
  • Last fund: May invest from a new fund soon — raised $9.2M in 2020

Portfolio highlights

  • Molmir — Molmir is a biotech company that conducts research and develops treatments for intractable diseases based on sensing technology.
  • EUV Photon — EUV Photon is an irradiation services company that conducts processing, evaluation, and measurement of materials for EUV lights.
  • Restore Vision — Restore Vision is a startup based in Japan aiming to develop a visual restoration gene therapy.
Show all investments...

SPARX Group
VC Fund · Tokyo, Tokyo, Japan · 3 investments in Japan Biotechnology startups

SPARX Group Co., Ltd. is an independent Asia-based equity and credit asset management services and Asian fund financial specialist with offices in Tokyo, Hong Kong and Seoul for global institutional and individual investors, including financial advisors and financial planners, with alternative strategies (including activist, short-enabled, private equity and quantitative and fund-of-funds) and mutual funds (through SPARX Asia Funds such as SPARX Asia Pacific Opportunities Fund, SPARX Asia Pacific Equity Income Fund, SPARX Japan Smaller Companies Fund and SPARX Japan Fund) managed or sub-advised by SPARX Asset Management Co. Ltd., SPARX Asia Investment Advisors Limited and Cosmo Asset Management Co., Ltd.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Information Technology
  • Stage:Venture - Series Unknown, Series B, Series A
  • Geography: Japan, United States, United Kingdom

Investor stats

  • Total investments: 84
  • Round size: Series A $3.7M–$142M; Series B $4.6M–$48M; Venture - Series Unknown $2.5M–$13M
  • Lead/follow: 32% lead, 68% follow
  • Last fund: May invest from a new fund soon — raised $128M in 2018

Portfolio highlights

  • Provigate — PROVIGATE is a provider of bio-transistor sensor technologies in Japan.The company's technologies are able to measure dynamic changes with the help of perception-broadening sensors, enabling individuals to change their habits for health
  • Spaceflux — As satellites become increasingly vital, Spaceflux tackles the growing challenges of orbital congestion and debris that put them at risk. Thanks to our proprietary global network of optical sensors, we provide data-driven space situational awareness services from LEO to Cislunar.
  • Alloyed — OxMet Technologies develops, licenses, and manufactures proprietary alloys, alloy powders and alloy components for the aerospace, automotive, industrial and biomedical markets.
Show all investments...

Biotechnology Investor funding in Japan at a glance

Stats across 626 deals from 666 investors.

666
investors
in Japan Biotechnology startups
626
deals
in Japan Biotechnology startups
$3.9M
median round
in Japan Biotechnology startups
33%
lead investors
lead at least one round
22%
Venture - Series Unknown
most common funding stage
98/2
VC / Angel
share of investor count

Access all 666 investors in Japan Biotechnology startups.

Open List

FAQ

Is Shizune data fresh/accurate?

Shizune has monitored hundreds of funding sources since 2020.

Our investor database is updated every day, so investor data is always fresh.

All metrics are calculated from confirmed public rounds, so the data is accurate.

Can I download investor list?

To download the Biotechnology Investors in Japan investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.

You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.

Can I access investor database?

To access all 666 investors investing in Japan Biotechnology startups and 48,091+ more investors, create a Shizune account.

Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.

The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.

You can enrich with email and download the data.

Does Shizune have investor emails and contacts?

Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.

To guarantee the highest discovery rate, we search across 20+ contact search tools.

To maximize delivery rate and reduce bounce rate, we validate emails.

You can enrich your investor list with Shizune. Download it too.

What is Shizune?

Shizune is a 48,091 investor database updated daily.

With Shizune you can:

  • browse the database
  • use smart matching
  • enrich with emails
  • download

All you need to find investors for your startup.

Who is Shizune for?

Shizune is built for startup founders by startup founders.

If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.

Is Shizune free?

Shizune is free forever. You can search and browse investors for free.

Email search and export are paid features.

For full info, visit our pricing.

Who built Shizune?

Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.

Contact 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!

More investor lists